US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
9/26/2014 | published by: MarketsandMarkets
... expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past ...  |  read more...
USD 4,650
Biotech Business October 2014
10/1/2014 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
USD 25
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
... diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the ...  |  read more...
USD 4,650
Anti-Inflammatory Peptides: Competitor Analysis
9/27/2014 | published by: La Merie Publishing
... 2014. Anti-Inflammatory peptides under development and on the market are used for treatment of diseases ranging from psoriasis, multiple sclerosis, transplantation and autoimmune diseases.Purchase of the downloadable pdf report includes a 6-month online access to ...  |  read more...
USD 319
BioMarker Strategies, LLC - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... next generation predictive tests - known as PathMap profiles - to guide targeted drug therapy selection for individual cancer patients. BioMarker Strategies is developing a pipeline of unique ex vivo biomarker tests to inform targeted ...  |  read more...
USD 750
Biosceptre International Limited - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... cancer. Biosceptre’s diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. The company has a series of product development programmes including polyclonal antibody, ...  |  read more...
USD 750
Global Joint Venture Partnerhsips in Pharma, Biotech and Diagnostics
10/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. This new 1st edition, includes: Trends in joint venture deals Joint venture agreement structure Joint venture contract documents Top joint venture deals by value Most active joint venture dealmakers ...  |  read more...
USD 1,995
Regenerative Medicine Partnering Terms and Agreements
10/1/2014 | published by: Current Partnering
... partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in regenerative medicine Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms ...  |  read more...
USD 2,995
Top 50 Big Biotech Partnering and M&A Deal Trends
10/1/2014 | published by: Current Partnering
... the worlds leading fifty big biotech companies. Top 50 Big Biotech Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big ...  |  read more...
USD 2,195
Bioinformatics Partnering Terms and Agreements
10/1/2014 | published by: Current Partnering
... in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for bioinformatics The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding ...  |  read more...
USD 2,995
Novartis AG - Product Pipeline Review - 2014
9/30/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Novartis AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Cavadis B.V. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... of development. Cavadis’s product CAV?RISK ASSAYS is used for cardiovascular indications, and CAV?RISK C?D is developed for coronary artery disease (CAD). The company’s products are developed for cardiovascular indications, including stroke, myocardial infarction (MI), and ...  |  read more...
USD 750
Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... development and Nanotrap lyme antigen test. Ceres Nanosciences’ Nanotrap particles are a protein enrichment toolset that can be integrated seamlessly into any existing downstream measurement and analysis process. The company’s Nanotrap High sensitivity lyme antigen ...  |  read more...
USD 750
Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... colon, stomach, leukemia, lung and prostate. Nuclea utilizes its proprietary DecisionDx platform in the development of in vitro companion diagnostics for use in therapeutic and medical imaging applications. It conducts research on novel molecular oncology ...  |  read more...
USD 750
OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... two kinds of tests to eradicate various kinds of cancers such as ImmunoPulse and NeoPulse. OncoSec’S ImmunoPulse is used to treat metastatic cancers. The company’s NeoPulse is used to treat primary and recurrent cancers that ...  |  read more...
USD 750
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
9/15/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Alpha MOS SA - Company Capsule
9/18/2014 | published by: Canadean Ltd
... major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Alpha MOS SA ...  |  read more...
USD 99
POCT Market in China : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the ...  |  read more...
USD 2,500
Applied Proteomics, Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... personalized medicine applications leading to better medical decisions and care. API’s proteomics platform technology uses a mass-spectrometry-based approach, principally tandem LCMS, to examine the biomarkers in a rapid and efficient process. The company collaborates with ...  |  read more...
USD 750
Compugen, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Compugen, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ...  |  read more...
USD 350
Cell Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
TiGenix N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' TiGenix N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Cesca Therapeutics, Inc. (formerly Thermogenesis Corp.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Cesca Therapeutics, Inc. (formerly Thermogenesis Corp.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ...  |  read more...
USD 350
1  2    4    6  7  8  9  10